187 related articles for article (PubMed ID: 33499882)
1. Identification of differentially methylated genes as diagnostic and prognostic biomarkers of breast cancer.
Mao XH; Ye Q; Zhang GB; Jiang JY; Zhao HY; Shao YF; Ye ZQ; Xuan ZX; Huang P
World J Surg Oncol; 2021 Jan; 19(1):29. PubMed ID: 33499882
[TBL] [Abstract][Full Text] [Related]
2. Identification of Methylation Markers and Differentially Expressed Genes with Prognostic Value in Breast Cancer.
Wu J; Zhang Y; Li M
J Comput Biol; 2019 Dec; 26(12):1394-1408. PubMed ID: 31290690
[TBL] [Abstract][Full Text] [Related]
3. Identification of methylation sites and signature genes with prognostic value for luminal breast cancer.
Xiao B; Chen L; Ke Y; Hang J; Cao L; Zhang R; Zhang W; Liao Y; Gao Y; Chen J; Li L; Hao W; Sun Z; Li L
BMC Cancer; 2018 Apr; 18(1):405. PubMed ID: 29642861
[TBL] [Abstract][Full Text] [Related]
4. Identification of aberrantly methylated differentially expressed genes in breast cancer by integrated bioinformatics analysis.
Yi L; Luo P; Zhang J
J Cell Biochem; 2019 Sep; 120(9):16229-16243. PubMed ID: 31081184
[TBL] [Abstract][Full Text] [Related]
5. Roadmap of DNA methylation in breast cancer identifies novel prognostic biomarkers.
de Almeida BP; Apolónio JD; Binnie A; Castelo-Branco P
BMC Cancer; 2019 Mar; 19(1):219. PubMed ID: 30866861
[TBL] [Abstract][Full Text] [Related]
6. Aberrant DNA methylation impacts gene expression and prognosis in breast cancer subtypes.
Győrffy B; Bottai G; Fleischer T; Munkácsy G; Budczies J; Paladini L; Børresen-Dale AL; Kristensen VN; Santarpia L
Int J Cancer; 2016 Jan; 138(1):87-97. PubMed ID: 26174627
[TBL] [Abstract][Full Text] [Related]
7. Methylation Profile of Small Breast Cancer Tumors Evaluated by Modified MS-HRM.
Krasnyi AM; Sadekova AA; Kometova VV; Rodionov VV; Yarotskaya EL; Sukhikh GT
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37628841
[TBL] [Abstract][Full Text] [Related]
8. A seven-DNA methylation signature as a novel prognostic biomarker in breast cancer.
Tao C; Luo R; Song J; Zhang W; Ran L
J Cell Biochem; 2020 Mar; 121(3):2385-2393. PubMed ID: 31646666
[TBL] [Abstract][Full Text] [Related]
9. CpG methylation signature predicts prognosis in breast cancer.
Du T; Liu B; Wang Z; Wan X; Wu Y
Breast Cancer Res Treat; 2019 Dec; 178(3):565-572. PubMed ID: 31520283
[TBL] [Abstract][Full Text] [Related]
10. Circulating cell-free DNA-based epigenetic assay can detect early breast cancer.
Uehiro N; Sato F; Pu F; Tanaka S; Kawashima M; Kawaguchi K; Sugimoto M; Saji S; Toi M
Breast Cancer Res; 2016 Dec; 18(1):129. PubMed ID: 27993161
[TBL] [Abstract][Full Text] [Related]
11. Identification of a DNA Methylation-Based Prognostic Signature for Patients with Triple-Negative Breast Cancer.
Gao Y; Wang X; Li S; Zhang Z; Li X; Lin F
Med Sci Monit; 2021 May; 27():e930025. PubMed ID: 34003815
[TBL] [Abstract][Full Text] [Related]
12. Methylation and transcriptome analysis reveal lung adenocarcinoma-specific diagnostic biomarkers.
Li R; Yang YE; Yin YH; Zhang MY; Li H; Qu YQ
J Transl Med; 2019 Sep; 17(1):324. PubMed ID: 31558162
[TBL] [Abstract][Full Text] [Related]
13. Integrative Analysis of DNA Methylation and Gene Expression to Determine Specific Diagnostic Biomarkers and Prognostic Biomarkers of Breast Cancer.
Zhang M; Wang Y; Wang Y; Jiang L; Li X; Gao H; Wei M; Zhao L
Front Cell Dev Biol; 2020; 8():529386. PubMed ID: 33365308
[No Abstract] [Full Text] [Related]
14. Significant prognostic values of differentially expressed-aberrantly methylated hub genes in breast cancer.
Qi L; Zhou B; Chen J; Hu W; Bai R; Ye C; Weng X; Zheng S
J Cancer; 2019; 10(26):6618-6634. PubMed ID: 31777591
[No Abstract] [Full Text] [Related]
15. Identification of biomarkers associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis.
Chen L; Lu D; Sun K; Xu Y; Hu P; Li X; Xu F
Gene; 2019 Apr; 692():119-125. PubMed ID: 30654001
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of aberrantly expressed methylation genes in human hepatocellular carcinoma.
Zhen L; Ning G; Wu L; Zheng Y; Yang F; Chen T; Xu W; Liu Y; Xie C; Peng L
Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 32955083
[TBL] [Abstract][Full Text] [Related]
17. Methylation status of TRAF2 is associated with the diagnosis and prognosis of gastric cancer.
Zhang J; Dai WJ; Yang XZ
Int J Clin Exp Pathol; 2015; 8(11):14228-34. PubMed ID: 26823737
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic values of GHSR DNA methylation pattern in breast cancer.
Botla SK; Gholami AM; Malekpour M; Moskalev EA; Fallah M; Jandaghi P; Aghajani A; Bondar IS; Omranipour R; Malekpour F; Mohajeri A; Babadi AJ; Sahin Ö; Bubnov VV; Najmabadi H; Hoheisel JD; Riazalhosseini Y
Breast Cancer Res Treat; 2012 Oct; 135(3):705-13. PubMed ID: 22899222
[TBL] [Abstract][Full Text] [Related]
19. Genome-wide analysis of cell-Free DNA methylation profiling with MeDIP-seq identified potential biomarkers for colorectal cancer.
Zhang X; Li T; Niu Q; Qin CJ; Zhang M; Wu GM; Li HZ; Li Y; Wang C; Du WF; Wang CY; Zhao Q; Zhao XD; Wang XL; Zhu JB
World J Surg Oncol; 2022 Jan; 20(1):21. PubMed ID: 35065650
[TBL] [Abstract][Full Text] [Related]
20. DNA methylation-based biomarkers in serum of patients with breast cancer.
Van De Voorde L; Speeckaert R; Van Gestel D; Bracke M; De Neve W; Delanghe J; Speeckaert M
Mutat Res; 2012; 751(2):304-325. PubMed ID: 22698615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]